Dyneric is used to treat infertility among female patients by stimulating increased hormones vital to the growth and release of mature eggs for ovulation.
Dyneric is available in tablet form and marketed under the brand names Clomin, Milophene, Serophene, Clomid, Clomiphene, Omifin, and Ikaclomin.
Patients having difficulty becoming pregnant may take Dyneric on it’s own or in conjunction with a medicine called Metformin to help patients ovulate and become pregnant.
Studies reveal that 70 % of patients who used Dyneric were able to ovulate, a good majority during the first months of treatment. Of that population, 15-50% were able to become pregnant.
Patients are prescribed 50 milligrams of Dyneric for 5 days beginning on the fifth day of their menstrual cycle. In case ovulation does not occur, dosage can be increased to 100 milligrams for 5 days the month after the previous dosage. It is not advised that patients take Dyneric after 6 treatment cycles.
Follow the dosing schedule set by your physician to get the best results. Patients should not take the medication for longer than prescribed. In case of a missed dose, patients should immediately talk with their physician to determine the next steps. It is not recommended to take double doses to resume your dosing schedule.
For best results, physicians may look into some factors, including the body temperature of the patient and ovulation tests prior to prescribing Dyneric.
Side effects include upset stomach, hot flashes, pelvic fullness, headache, breast tenderness, or dizziness. If these symptoms persist, patients should immediately notify their physicians. In general, the chances of a patient experiencing these side effects are low.
Changes in the patient’s vision, such as seeing flashes, is another possible side effect while taking Dyneric. This is more common if the patient is exposed to intense lighting. If a patient does experience this side effect, it may go away after a couple of days after treatment. If it does not go away on it’s own, consult your doctor.
Serious side effects include vaginal bleeding and changes in moods. Some patients may experience severe pain or swelling in the pelvic area, diarrhea, difficulty in breathing, chest pain, irregular heartbeat, nausea, and swelling of the legs.
Before taking Dyneric, women should inform their physician about any history of allergies to medications. Patients should also consult their physician about their conditions such as liver disease, vaginal bleeding, uncontrolled thyroid, and pituitary tumor before agreeing to use Dyneric.
There have been cases where the use of Dyneric resulted in the patient having multiple births like twins and triplets.
Women are advised against engaging in activities that require mental alertness such as driving since Dyneric can make a person dizzy or suffer from blurred vision.
Patients should tell their physician or pharmacist about all the prescription medicines they are using before taking Dyneric.
Dyneric has the following structural formula:
• Molecular formula of dyneric is C26H28ClNO
• Chemical IUPAC Name is 2-[4-[(Z)-2-chloro-1,2-di(phenyl)ethenyl]phenoxy]-N,N-diethylethanamine
• Molecular weight is 405.9596 g/mol
• Dyneric available : 50mg tablets
©2007-2017 Medicalook.com All rights reserved